Mr. Alex Somjen reports
GLOBAL CARE CAPITAL ANNOUNCES SALE OF SUBSIDIARY
Global Care Capital Inc. has executed a share purchase agreement dated June 29, 2020, for the sale of all of the issued and outstanding common shares of its wholly owned subsidiary, ReFormation Pharmaceuticals Corp., to an arm's-length purchaser, 360 Life Sciences Corp. of Delaware, United States. Under the terms of the agreement, the purchaser will acquire the ReFormation shares in exchange for 800,000 common shares in the capital of the purchaser.
The agreement contains standard representations, warranties, indemnities and covenants for transactions of this nature. No finders' fees will be paid in connection with the agreement.
The previously announced share purchase agreement entered into by the company and the purchaser dated March 31, 2020, was terminated on April 30, 2020.
About Global Care Capital Inc.
Global Care Capital is a global investment company that specializes in providing early-stage financing to private and public companies.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.